FBRX — Forte Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Forte Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	58.8	42	41.1	37.1	58.4
Prepaid Expenses
Total Other Current Assets
Total Current Assets	59.9	42.5	41.5	38.3	61.3
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.097	0	—	0.109	0.077
Long Term Notes Receivable
Other Long Term Assets
Total Assets	61.2	43.3	42	39	61.6
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	2.26	1.76	3.18	3.67	9.08
Total Long Term Debt
Total Debt
Total Liabilities	2.26	1.76	3.18	3.67	9.08
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	59	41.5	38.8	35.3	52.5
Total Liabilities & Shareholders' Equity	61.2	43.3	42	39	61.6
Total Common Shares Outstanding